Literature DB >> 7649198

Failure of pristinamycin treatment in a case of pneumococcal pneumonia.

C Burucoa1, T Pasdeloup, C Chapon, J L Fauchère, R Robert.   

Abstract

A case of pneumonia caused by Streptococcus pneumoniae occurring in a patient receiving pristinamycin is reported. Despite empirical treatment with pristinamycin, 2 g/day for five days, the patient's condition worsened. Protected brush specimen and blood cultures permitted isolation of Streptococcus pneumoniae. MIC testing indicated that the strain was susceptible to pristinamycin and resistant to erythromycin and penicillin. Streptococcus pneumoniae was eradicated by cefotaxime, and pneumonia resolved. This case underlines the fact that pristinamycin may not be suitable for the treatment of multiresistant pneumococcal infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649198     DOI: 10.1007/bf02116528

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

Review 1.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Single oral dose pharmacokinetics of the two main components of pristinamycin in humans.

Authors:  C Koechlin; J F Kempf; F Jehl; H Monteil
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

3.  Resistance of two strains of Streptococcus pneumoniae to pristinamycin associated with 16-membered macrolides.

Authors:  J P Emond; A Fremaux; A Dublanchet; G Sissia; P Geslin; A Sedalian; G Lionsquy
Journal:  Pathol Biol (Paris)       Date:  1989-09

4.  [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].

Authors:  A Fremaux; G Sissia; P Geslin
Journal:  Pathol Biol (Paris)       Date:  1993-09

5.  Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae.

Authors:  K K Krisher; A Linscott
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

  5 in total
  4 in total

1.  Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies.

Authors:  L Schlegel; G Sissia; A Frémaux; P Geslin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 2.  Epidemiology, control and treatment of multiresistant pneumococci.

Authors:  K P Klugman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Streptogramins and their potential role in geriatric medicine.

Authors:  B M Lomaestro; L L Briceland
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

4.  Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa.

Authors:  C A Widdowson; K P Klugman
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.